A detailed history of Clari Vest Asset Management LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 22,964 shares of DNLI stock, worth $533,224. This represents 0.07% of its overall portfolio holdings.

Number of Shares
22,964
Previous 22,964 -0.0%
Holding current value
$533,224
Previous $533,000 25.33%
% of portfolio
0.07%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$14.96 - $23.22 $370,768 - $575,484
-24,784 Reduced 51.91%
22,964 $533,000
Q1 2024

May 06, 2024

BUY
$15.83 - $23.35 $119,801 - $176,712
7,568 Added 18.84%
47,748 $979,000
Q4 2023

Feb 13, 2024

SELL
$16.2 - $23.18 $44,080 - $63,072
-2,721 Reduced 6.34%
40,180 $862,000
Q3 2023

Nov 13, 2023

BUY
$20.63 - $30.17 $783 - $1,146
38 Added 0.09%
42,901 $885,000
Q2 2023

Aug 14, 2023

SELL
$23.37 - $32.96 $149,661 - $211,075
-6,404 Reduced 13.0%
42,863 $1.26 Million
Q1 2023

May 08, 2023

BUY
$21.91 - $32.67 $854 - $1,274
39 Added 0.08%
49,267 $1.14 Million
Q4 2022

Feb 14, 2023

SELL
$26.28 - $33.92 $3,994 - $5,155
-152 Reduced 0.31%
49,228 $1.37 Million
Q3 2022

Nov 10, 2022

SELL
$25.97 - $38.53 $136,550 - $202,590
-5,258 Reduced 9.62%
49,380 $1.51 Million
Q2 2022

Aug 12, 2022

SELL
$20.88 - $35.19 $229,680 - $387,090
-11,000 Reduced 16.76%
54,638 $1.61 Million
Q4 2021

Feb 14, 2022

SELL
$42.59 - $55.02 $248,214 - $320,656
-5,828 Reduced 8.15%
65,638 $2.93 Million
Q3 2021

Nov 08, 2021

SELL
$48.48 - $78.23 $183,205 - $295,631
-3,779 Reduced 5.02%
71,466 $3.61 Million
Q2 2021

Aug 09, 2021

BUY
$50.3 - $78.44 $2.92 Million - $4.55 Million
58,039 Added 337.32%
75,245 $5.9 Million
Q1 2021

May 13, 2021

BUY
$53.8 - $81.53 $25,447 - $38,563
473 Added 2.83%
17,206 $982,000
Q4 2020

Feb 09, 2021

SELL
$36.89 - $93.56 $839,763 - $2.13 Million
-22,764 Reduced 57.63%
16,733 $1.4 Million
Q3 2020

Nov 09, 2020

BUY
$23.13 - $38.84 $188,694 - $316,856
8,158 Added 26.03%
39,497 $1.41 Million
Q2 2020

Aug 12, 2020

BUY
$16.01 - $28.82 $501,737 - $903,189
31,339 New
31,339 $757,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.12B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.